Wyatt Technology introduces the most advanced and versatile system for the separation and sizing of macromolecules and sub-micrometer particles in aqueous solutions.
Wyatt Technology introduces the most advanced and versatile system for the separation and sizing of macromolecules and sub-micrometer particles in aqueous solutions. The Eclipse is analogous to an HPLC system—only applied to the separation of particles and large molecules.
The Eclipse can be used for very large macromolecules that cannot be separated by conventional Gel Filtration Chromatography, and its gentle separation assures that shear forces are eliminated or reduced to the absolute minimum.
It interfaces seamlessly with Wyatt Technology’s DAWN multi-angle light scattering instruments and software to determine rapidly and reliably absolute particle size distributions and molecular weights without reference to any standards.
Contact: Geofrey Wyatt
Tel: 805-681-9009
Fax: 805-681-0123
E-mail:info@wyatt.com
The Complexity of Oligonucleotide Separations
January 9th 2025Peter Pellegrinelli, Applications Specialist at Advanced Materials Technology (AMT) explains the complexity of oligonucleotide separations due to the unique chemical properties of these molecules. Issues such as varying length, sequence complexity, and hydrophilic-hydrophobic characteristics make efficient separations difficult. Separation scientists are addressing these challenges by modifying mobile phase compositions, using varying ion-pairing reagents, and exploring alternative separation modes like HILIC and ion-exchange chromatography. Due to these complexities, AMT has introduced the HALO® OLIGO column, which offers high-resolution, fast separations through its innovative Fused-Core® technology and high pH stability. Alongside explaining the new column, Peter looks to the future of these separations and what is next to come.
Metabolomics Analysis of Low Birth-Weight Infants Using UHPLC-MS/MS Following Lipid Emulsion
January 10th 2025A recent study aimed to directly compare the changes in serum metabolites among very low birth-rate (VLBW) infants following the administration of the soybean oil-based lipid emulsion and soybean oil, medium-chain triglycerides, olive oil, and fish oil (SMOF) lipid emulsion using untargeted metabolomics techniques.
Analyzing New Drug Modalities: An ISC 2024 Interview with Kelly Zhang
January 10th 2025At ISC 2024 in Liverpool, United Kingdom, LCGC International interviewed Kelly Zhang of Genentech about her work analyzing new drug modalities, such as mRNA, oligonucleotides, peptides, and cell and gene therapies.